Haematologica (May 2011)

Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physicians

  • Esther N. Oliva,
  • Francesco Nobile,
  • Giuliana Alimena,
  • Francesca Ronco,
  • Giorgina Specchia,
  • Stefana Impera,
  • Massimo Breccia,
  • Iolanda Vincelli,
  • Ida Carmosino,
  • Patrizia Guglielmo,
  • Domenico Pastore,
  • Caterina Alati,
  • Roberto Latagliata

DOI
https://doi.org/10.3324/haematol.2010.036715
Journal volume & issue
Vol. 96, no. 5

Abstract

Read online

Background The aim of this study was to evaluate changes in quality of life scores and their association with therapy and survival in unselected elderly patients with acute myeloid leukemia.Design and Methods From February 2003 to February 2007, 113 patients aged more than 60 years with de novo acute myeloid leukemia were enrolled in a prospective observational study. Two different quality of life instruments were employed: the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire – C30 (EORTC QLQ-C30) and a health-related quality of life questionnaire for patients with hematologic diseases (QOL-E).Results Forty-eight patients (42.4%) received intensive chemotherapy and 65 (57.6%) were given palliative treatments. Age greater than 70 years (P=0.007) and concomitant diseases (P=0.019) had a significant impact on treatment allocation. At diagnosis, general quality of life was affected [median QOL-E standardized score 54, interquartile range 46–70; median EORTC global score 50, interquartile range 41–66]. Most patients were given a good ECOG Performance Status (< 2), which did not correlate with the patients’ perception of quality of life. At multivariate analysis, palliative approaches (P=0.016), age more than 70 years (P=0.013) and concomitant diseases (P=0.035) each had an independent negative impact on survival. In a multivariate model corrected for age, concomitant diseases and treatment option, survival was independently predicted by QOL-E functional (P=0.002) and EORTC QLQ-C30 physical function (P=0.030) scores.Conclusions Quality of life could have an important role in elderly acute myeloid leukemia patients at diagnosis as a prognostic factor for survival and a potential factor for treatment decisions.